Lv63
2330 积分 2024-02-20 加入
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Metastatic papillary gallbladder carcinoma with a unique presentation and clinical course
1个月前
已完结
Diabetic Cholecystomegaly
1个月前
已完结
Plasma FSTL-1 as a non-invasive diagnostic biomarker for patients with advanced liver fibrosis
1个月前
已完结
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
1个月前
已完结
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
1个月前
已完结
Can we use old NAFLD data under the new MASLD definition?
1个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease at Quantitative US: International Prospective Study
2个月前
已完结
Epidemiological Features of NAFLD From 1999 to 2018 in China
2个月前
已完结
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
2个月前
已完结
皖公网安备34019202002308
